CVR number 16682780
Industry 32.5000 Manufacture of medical and dental instruments and supplies

SAND MADSEN DENTAL ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  5.0% 2.9% 3.1% 3.8% 6.4%  
Credit score (0-100)  45 58 55 50 36  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  547 563 549 386 343  
EBITDA  18.6 116 16.4 -60.0 -13.6  
EBIT  -52.1 36.4 -42.3 -115 -68.7  
Pre-tax profit (PTP)  -72.6 26.3 -49.0 -129.2 -91.3  
Net earnings  -59.5 20.3 -39.1 -101.1 -120.6  
Pre-tax profit without non-rec. items  -72.6 26.3 -49.0 -129 -91.3  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  322 242 184 129 73.5  
Shareholders equity total  239 259 220 119 -2.0  
Interest-bearing liabilities  29.0 213 194 236 216  
Balance sheet total (assets)  698 639 493 438 323  
Net Debt  -12.7 187 193 235 215  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  547 563 549 386 343  
Gross profit growth  -8.4% 2.9% -2.5% -29.6% -11.1%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  698 639 493 438 323  
Balance sheet change%  -15.8% -8.5% -22.9% -11.1% -26.3%  
Added value  18.6 116.1 16.4 -56.4 -13.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -141 -159 -117 -110 -110  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 -2.0 -3.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -9.5% 6.5% -7.7% -29.8% -20.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -6.8% 5.4% -7.5% -24.7% -18.0%  
ROI %  -15.3% 9.6% -9.5% -30.0% -24.1%  
ROE %  -19.3% 8.2% -16.4% -59.8% -54.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  34.2% 40.5% 44.6% 27.1% -0.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -68.2% 160.9% 1,175.4% -391.7% -1,586.4%  
Gearing %  12.1% 82.2% 88.3% 198.8% -10,920.1%  
Net interest  0 0 0 0 0  
Financing costs %  141.8% 8.4% 3.3% 6.6% 10.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.4 0.5 0.5 0.4 0.2  
Current Ratio  0.8 1.0 1.1 0.9 0.7  
Cash and cash equivalent  41.7 26.0 0.7 0.7 0.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -84.8 13.2 24.1 -21.9 -87.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  19 116 16 -56 -14  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  19 116 16 -60 -14  
EBIT / employee  -52 36 -42 -115 -69  
Net earnings / employee  -60 20 -39 -101 -121